# Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

> **NCT04000698** · PHASE3 · UNKNOWN · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 25 (estimated)

## Conditions studied

- Refractory Acute Myeloid Leukemia
- Refractory Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Preparative regimen

## Key facts

- **NCT ID:** NCT04000698
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-15
- **Primary completion:** 2022-07
- **Final completion:** 2022-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04000698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04000698, "Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04000698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*